These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 590978)

  • 1. Role of uridine entrapped in liposomes in galactosamine-induced hepatitis.
    Mathias C; Dorai DT; Bachhawat BK
    Indian J Biochem Biophys; 1977 Jun; 14(2):142-6. PubMed ID: 590978
    [No Abstract]   [Full Text] [Related]  

  • 2. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition, by drugs, of galactosamine induced hepatitis in the rat.
    Pickering RW; Lynn James GW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.
    Liehr H; Heine WD
    Hepatogastroenterology; 1981 Dec; 28(6):296-8. PubMed ID: 7345010
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis].
    Bauer C; Reutter W; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1502. PubMed ID: 4649767
    [No Abstract]   [Full Text] [Related]  

  • 6. [The anti-hepatotoxic effect of parenterally administered silymarin in galactosamine hepatitis of the rat].
    Schriewer H; Rausen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:159. PubMed ID: 4740687
    [No Abstract]   [Full Text] [Related]  

  • 7. Early, reversible plasma membrane injury in galactosamine-induced liver cell death.
    El-Mofty SK; Scrutton MC; Serroni A; Nicolini C; Farber JL
    Am J Pathol; 1975 Jun; 79(3):579-96. PubMed ID: 1137005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective and curative effects of diethyldithiocarbamate on galactosamine hepatitis in the rat (author's transl)].
    Homann J; Gerhardt H; Hopf F
    Arzneimittelforschung; 1980; 30(4):645-7. PubMed ID: 6249330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effects of 5-fluorouridine and uridine on d-galactosamine-induced liver injury.
    Holstege A; Anukarahanonta T; Yamamoto M; Koch HK; Kattermann R; Lesch R; Keppler D
    Exp Mol Pathol; 1981 Apr; 34(2):170-82. PubMed ID: 6162676
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antihepatotoxic activity of arginine thiazolidinecarboxylate in hepatitis induced by galactosamine in the rat].
    Carminati R; Falchi M; Nebuloni R; Guadagni L; Lodi R
    Farmaco Prat; 1979 Apr; 34(4):163-7. PubMed ID: 456554
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of silymarin on experimental liver lesions.
    Barbarino F; Neumann E; Deaciuc I; Ghelberg NW; Suciu A; Cotuţiu C; Racoviţă L; Stroilă C; Nagy S; Părău N; Toader S; Brilinschi C
    Med Interne; 1981; 19(4):347-57. PubMed ID: 7336095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in polyamine metabolism of rat liver after administration of D-galactosamine. Favorable effects of putrescine administration on galactosamine-induced hepatic injury.
    Daikuhara Y; Tamada F; Takigawa M; Takeda Y; Mori Y
    Gastroenterology; 1979 Jul; 77(1):123-32. PubMed ID: 447009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 14. The protective effect of a novel compound RU 18492, on galactosamine-induced hepatotoxicity in the rat.
    James GW; Pickering RW
    Arzneimittelforschung; 1976; 26(12):2197-9. PubMed ID: 1037274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of Polyporus umbellatus polysaccharide on toxic hepatitis in mice].
    Lin YF; Wu GL
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):345-8. PubMed ID: 3195347
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective uptake of liposomes by different cell types of liver through the involvement of liposomal surface glycosides.
    Ghosh P; Das PK; Bachhawat BK
    Biochem Soc Trans; 1981 Dec; 9(6):512-4. PubMed ID: 7308565
    [No Abstract]   [Full Text] [Related]  

  • 17. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

  • 19. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of uridine diphosphoglucose dehydrogenase by galactosamine-I-phosphate and UDP-galactosamine.
    Bauer C; Reutter W
    Biochim Biophys Acta; 1973 Jan; 293(1):11-4. PubMed ID: 4734370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.